These experiments yielded unequivocal results using NIH3T3 cell transformation assays, and of greater relevance to hematopoietic cancers, using the hematopoietic IL3-dependent cell line 32D. This evidence concerns the gene IL3 and hematopoietic and lymphoid cell neoplasm.